DSS does not have enough credible, current analyst coverage to support a reliable consensus. MarketBeat lists no consensus rating or price target for the stock, and only a single visible analyst estimate — near $3.00 — appears in third-party trackers. Because one extreme estimate cannot form a meaningful aggregate, the $0.70 figure used here comes instead from public technical discussion: a reclaim of the 200-day moving average, which recently sat near $0.69, and the first meaningful overhead supply zone above current levels. That single $3.00 estimate is noted only as context and is not treated as a dependable target. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
DSS recently traded around $0.49, well below its 52-week high of about $1.86 and modestly above its 52-week low near $0.36. Reaching $0.70 would require a rise of roughly 43%, which represents a substantial move for a stock that has struggled to sustain upward momentum. The path would likely require first stabilizing above recent lows, then clearing the 50-day moving average near $0.63 before challenging the $0.69–$0.70 zone. The company's fundamentals remain weak, with trailing-twelve-month revenue near $18.5 million, a net loss of roughly $27 million, and negative diluted EPS of about $2.94.
A rebound toward $0.70 would most plausibly be driven by technical mean-reversion and improved sentiment rather than earnings alone. The stock trades at a depressed price-to-sales ratio near 0.27, and any improvement in its packaging or biotechnology segments — such as resolving customer onboarding delays that pressured recent results — could lift confidence. A broader risk-on environment for micro-cap and speculative equities, along with short interest that has recently declined, could also reduce selling pressure and support a recovery toward the 200-day moving average.
The obstacles are substantial. The company is unprofitable, reported a roughly 32% year-over-year revenue decline in its most recent quarter, and carries a negative book value per share. Total debt is far larger than cash on hand, and the debt-to-equity ratio is extreme. The stock remains in a longer-term downtrend and sits below both its 50-day and 200-day moving averages, indicating persistent technical weakness. Insiders have been net sellers in recent months, and the company's diversified but fragmented business mix offers no clear near-term catalyst.
From a technical standpoint, support sits near the 52-week low around $0.36 and in the $0.42 area identified in recent technical commentary. Overhead resistance begins at the 50-day moving average near $0.63, with the 200-day moving average around $0.69 — the level represented by the $0.70 target — acting as the first major barrier. Beyond that, a prior resistance zone near $0.83 would need to be cleared for a more durable recovery. The stock's wide daily ranges and thin trading volumes make these levels less reliable than for larger, more liquid names. I also checked this using Tickeron’s AI Trend Prediction Engine to review the longer-term pattern context.
Analyst price targets typically reflect a roughly 12-month horizon, but with only one extreme estimate available, no meaningful time frame can be attached to DSS. Investors should monitor the company's next quarterly results, any updates on packaging customer onboarding and segment performance, changes in cash burn and debt levels, and whether shares can hold above recent lows. Broader micro-cap sentiment and any capital-raising activity, which could dilute existing shareholders, are also important signals for whether a move toward $0.70 is realistic.
In my own work, Tickeron's AI Daily Buy/Sell Signals have helped me monitor volatile names like this more systematically. The tool scans thousands of stocks and ETFs daily, producing Buy, Sell, or Hold signals based on technical behavior and AI analysis. For thinly traded micro-caps, it offers an efficient way to track trend shifts without relying solely on manual review, and I find it complements traditional charting when assessing recovery potential.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
DSS moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend. In 49 of 50 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The 10-day moving average for DSS crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DSS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for DSS entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DSS's RSI Oscillator exited the oversold zone, 28 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
Following a +5.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where DSS advanced for three days, in 146 of 197 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
DSS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: DSS's P/B Ratio (-12.911) is very low in comparison to the industry average of (1.266). P/E Ratio (-0.167) is within average values for comparable stocks, (16.239). Projected Growth (PEG Ratio) (0.130) is also within normal values, averaging (1.023). DSS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.033). P/S Ratio (0.381) is also within normal values, averaging (1.259).
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. DSS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of security and anti-counterfeiting technologies
Industry ContainersPackaging